Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Andrologia ; 49(6)2017 Aug.
Article in English | MEDLINE | ID: mdl-27484696

ABSTRACT

To evaluate the protective effects of Resveratrol (RES) on azoxymethane (AOM)-induced testicular damage using histopathology and biochemical analyses, 28 male rats were randomly divided into four groups. Groups were control, RES, AOM and ARES. At the end of the 7 weeks, following routine tissue processing procedure, testis sections were stained with haematoxylin-eosin and Masson's trichrome. The blood samples were taken for biochemical analysis of testosterone, total oxidative stress, total antioxidant status and oxidative stress index. Degenerative changes in the seminiferous tubules such as atrophy, loss in the number of germ cells and arrested spermatogenic cell, and increase in the connective tissue of the tunica albuginea in the groups with AOM treatment were found. RES treatment (ARES) reduced the number of affected seminiferous tubules significantly (p < .05) compared to AOM alone. The testosterone levels in AOM group were significantly lower than in the control group (p < .05). The total oxidative stress levels were significantly higher in AOM group compared to control group (p < .05). The total antioxidant status levels in ARES group were significantly higher than in the AOM group (p < .05). This study results suggest that an antioxidant like Resveratrol may be useful for decreasing the harmful effects of azoxymethane.


Subject(s)
Antioxidants/pharmacology , Azoxymethane/pharmacology , Carcinogens/pharmacology , Oxidative Stress/drug effects , Stilbenes/pharmacology , Testis/drug effects , Testosterone/blood , Animals , Male , Rats , Resveratrol , Seminiferous Tubules/drug effects , Seminiferous Tubules/metabolism , Testis/metabolism
2.
Transplant Proc ; 42(9): 3820-2, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21094863

ABSTRACT

Zoledronic acid (ZA), a nitrogen-bearing bisphosphonate, is used to treat the hypercalcemia associated with cancer. In addition to its antiumor effects, it acts as an osteoclast inhibitor. To investigate the effects of ZA on oxidative stress and antioxidants, we studied reduced glutathione (GSH) and antioxidant gamma glutamate cysteine, including nitrite and nitrate, which are endproducts of nitric oxide (NO) as well as malondialdehyde (MDA) in rabbit liver tissue. In the study ZA (100 µg/kg) was administered to 7 rabbits that were fed ad libitum for comparison with untreated controls. MDA was studied using Thiobarbituric acid-reactive substance reduction, NO using cadmium reduction, GSH using an enzymatic method yielding dithinitrobenzene yellow substance. We observed significantly higher MDA and NO levels in the ZA group (P < .0001), whereas GSH levels were significantly lower (P < .0001). Tissues were examined histopathologically. According to our results we find ZA induced rabbit liver oxidative stress and decreases with antioxidant levels in liver tissue. Further studies are needed to explore the safe use of this agent.


Subject(s)
Antioxidants/metabolism , Bone Density Conservation Agents/pharmacology , Diphosphonates/pharmacology , Imidazoles/pharmacology , Liver/drug effects , Oxidants/metabolism , Oxidative Stress/drug effects , Animals , Dipeptides/metabolism , Glutathione/metabolism , Liver/metabolism , Malondialdehyde/metabolism , Nitrates/metabolism , Nitrites/metabolism , Rabbits , Zoledronic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...